Nephron targets better health care using smart contracts
Client(s) Nephron Pharmaceuticals Corporation
Jones Day is providing intellectual property advice to Nephron Pharmaceuticals Corporation's blockchain venture that seeks to track outpatient compliance using next generation handheld drug delivery devices and digital ledger infrastructure. The technology will provide a connected ecosystem and chain of data provenance between manufacturers, hospitals, health care providers, auditors, and regulators.